Table 13.

Treatment of ROP and Oxygen Dependence Among Survivors

Gestational Age (Weeks)Treated ROPSupplemental Oxygen
at 36 Weeks' PMA at 40 Weeks' PMA
n/Number Reporting
(%, 95% CI)
n/Number Reporting
(%; 95% CI)
n/Number Reporting
(%, 95% CI)
≤237/27 (25.9; 11.1–46.3)24/28 (85.7; 67.3–96.0)21/28 (75.0; 55.1–89.3)
2420/100 (20.0; 12.7–29.2)77/100 (77.0; 67.5–84.8)62/100 (62.0; 51.7–71.5)
2518/182 (9.9; 6.0–15.2)130/186 (69.9; 62.8–76.4)78/186 (41.9; 34.8–49.4)
Total discharges45/309 (14.6; 10.8–19.0)231/314 (73.6; 68.3–78.4)161/314 (51.3; 45.6–56.9)
χ2 for trend8.2 3.99 17.1
Pvalue .004 .046 .00004